Postdoctoral Position - Cancer Genomics and Precision Oncology
Memorial Sloan Kettering Cancer Center (MSKCC) is a world renowned organization dedicated to the progressive control and cure of cancer through programs of patient care, research, and education.
The Berger laboratory is a group of experimental and computational scientists dedicated to the characterization of genetic mutations in human tumors in order to identify biomarkers of cancer progression and drug response. Using massively parallel next-generation DNA and RNA sequencing, the lab is developing and applying methods to profile individual patient-derived specimens including tumor tissue and circulating tumor DNA for somatic base mutations and other genomic aberrations that may influence response to therapy. Having established the capability to prospectively sequence patients’ tumors to guide treatment selection, we are analyzing the vast clinical-genomic data set of annotated tumor specimens spanning all cancer subtypes to identify prognostic and predictive biomarkers.
The Berger laboratory is seeking an outstanding postdoctoral fellow with a strong record in computational biology and a desire to develop and apply bioinformatics methods to problems in translational cancer biology. The successful candidate will interact with investigators with expertise in bioinformatics, genomic technology, cancer biology, molecular pathology, and clinical oncology. She/he will be an innovative thinker, exceptional communicator, self-motivated and organized, and will enjoy working with an interdisciplinary team.
Learn more about the lab here - https://www.mskcc.org/research-areas/labs/michael-berger
The postdoctoral fellow will be jointly mentored by Dr. Michael Berger (Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology) and Dr. Ahmet Zehir (Director of Clinical Bioinformatics in the Department of Pathology). Projects will leverage the vast data set of tumor and germline genomic profiles and corresponding clinical data from more than 30,000 patients treated at MSKCC. In particular, the fellow will explore the prevalence of, the mechanistic basis of, and the clinical consequences of clonal hematopoiesis using this unique resource. Additional projects will utilize high-throughput tissue and ‘liquid biopsy’ sequencing data for the characterization of somatic and germline biomarkers, which can be prospectively applied to inform prognosis and guide treatment selection for patients under active care.
Applicants should hold a PhD and/or MD degree and have strong analytical and programming skills. Significant experience in cancer biology and genomic technology is highly desired. Outstanding English communication skills, organizational skills, and attention to detail are required.
Memorial Sloan Kettering Cancer Center is an equal opportunity employer with a strong commitment to enhancing the diversity of its faculty and staff. Women and applicants from diverse racial, ethnic and cultural backgrounds are encouraged to apply.
Please send CV, a letter outlining your interest and names/contact information of three references via email to:
Dr. Michael F. Berger
Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, NY 10065
MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.